Jagsonpal Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals has submitted a certificate to the stock exchange as required under SEBI's Depositories and Participants Regulations, 2018. This is a routine compliance filing typically related to the company's reconciliation of physical and dematerialized (demat) shares, or confirmation of share capital data with the depositories. No specific financial numbers, share counts, or operational details were disclosed in the headline. The filing is purely procedural and meant to affirm that the company is meeting its regulatory obligations regarding how its shares are held and recorded.
This is a standard regulatory submission with no expected impact on the stock price or shareholder value. Investors can view it as confirmation that the company remains in good standing on compliance matters related to share records and depositories.